Geraghty S, Kleinert D
Mountain States Regional Hemophilia Center, University of Colorado Health Science Center, Denver, USA.
J Intraven Nurs. 1998 Mar-Apr;21(2):70-5.
To obtain information on venous access devices (VADs) used for the treatment of patients with hemophilia and infections associated with the use of VADs, a questionnaire was sent to 153 hemophilia treatment centers in the United States and Puerto Rico. Information regarding the treatment of 10,421 patients and 568 VADs was obtained. Infections were reported with 159 (45%) of 353 internal devices and 126 (71%) of 178 external devices. These results indicate that VADs used for the treatment of hemophilia are associated with significantly higher infection rates than are those used in oncology or mixed patient populations.
为获取用于治疗血友病患者的静脉通路装置（VADs）以及与使用VADs相关的感染的信息，向美国和波多黎各的153个血友病治疗中心发送了一份调查问卷。获得了有关10421名患者和568个VADs的治疗信息。在353个内置装置中有159个（45%）报告发生感染，在178个外置装置中有126个（71%）报告发生感染。这些结果表明，用于治疗血友病的VADs的感染率显著高于用于肿瘤学或混合患者群体的VADs。
